Idexx Laboratories Deferred stock units: Outstanding: 60 units in 2026 and 59 units in 2025 increased by 1.2% to $6.17M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.3%, from $5.86M to $6.17M. Over 5 years (FY 2020 to FY 2025), Deferred stock units: Outstanding: 60 units in 2026 and 59 units in 2025 shows an upward trend with a 6.2% CAGR.
An increase reflects higher reliance on equity-based incentives, which aligns employee interests with shareholders but may lead to future dilution.
This captures specific equity-linked instruments, such as deferred stock units or restricted stock units, granted to emp...
Common in companies with significant stock-based compensation; comparable to other firms' equity incentive plans.
other_common_stock_other_value_outstanding| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.63M | $5.67M | $5.72M | $5.77M | $5.17M | $5.18M | $5.18M | $5.16M | $5.52M | $5.52M | $5.53M | $5.51M | $5.89M | $5.89M | $5.89M | $5.86M | $6.23M | $6.23M | $6.09M | $6.17M |
| QoQ Change | — | +0.7% | +0.9% | +0.8% | -10.3% | +0.1% | +0.1% | -0.3% | +6.8% | +0.1% | +0.1% | -0.4% | +6.8% | +0.0% | +0.0% | -0.5% | +6.4% | +0.0% | -2.2% | +1.2% |
| YoY Change | — | — | — | — | -8.2% | -8.7% | -9.4% | -10.4% | +6.7% | +6.7% | +6.7% | +6.7% | +6.7% | +6.6% | +6.4% | +6.3% | +5.8% | +5.8% | +3.6% | +5.3% |